This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Psoriasis
  • /
  • Data on the safety of psoriasis therapies
Journal

Data on the safety of psoriasis therapies

Read time: 1 mins
Published:1st Jun 2014
Author: Leonardi CL.
Availability: Free full text
Ref.:Semin Cutan Med Surg. 2014 Jun;33(4 Suppl):S73-5.
DOI:10.12788/j.sder.0099
Data on the safety of psoriasis therapies


Safety remains paramount to the clinical utility of a therapy. Evaluation of safety is an ongoing process that does not end when a therapy becomes commercially available. This article reviews recent data pertaining to the safety profile of two therapeutic classes widely used in the treatment of psoriasis: inhibitors of tumor necrosis factor-α and agents that target interleukin-12/23.


Read abstract on library site    Access full article